This bill adds a new section (1709D) to Title 38 directing the Secretary of Veterans Affairs to create a Prosthetic and Rehabilitative Items and Services Formulary for items and services furnished under VA medical care. It tasks the VA with developing the formulary using evidence, soliciting public and veteran input, and ensuring the items and services on it are available at or through all VA facilities.
Why it matters: the measure centralizes what prosthetic and rehabilitative items the VA will offer, pairs that standardization with explicit requirements on publication, training, contracting, and an exception-and-monitoring process for non-formulary care. That combination shifts procurement, clinical workflows, and vendor dynamics across the VA health system and will change how veterans access specialized devices and services.
At a Glance
What It Does
The bill requires the Secretary to establish and maintain a formal list (the Formulary) of prosthetic and rehabilitative items and services, to publish and periodically update it on a VA website, and to solicit input from veterans and the public. It directs the VA to enter contracts and provide clinician and staff training to support availability, to create an exceptions process for medically necessary non-formulary items, and to monitor those exceptions to inform formulary additions.
Who It Affects
Directly affects veterans who receive prosthetic and rehabilitative care, VA clinicians and facility administrators responsible for prescribing and furnishing devices, VA procurement and logistics offices, and manufacturers and suppliers of prosthetic devices and rehabilitation services that contract with the VA.
Why It Matters
By standardizing a national list and tying availability to all VA facilities, the bill reduces regional variability in what VA furnishes and concentrates purchasing and distribution decisions. That can improve transparency and bargaining leverage but also requires the VA to redesign clinical workflows, contracting practices, inventory management, and appeals communication to veterans.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a single, VA-managed formulary for prosthetic and rehabilitative items and services. Rather than leaving device selection and availability to local practice or ad hoc procurement, the VA will codify which items and services are part of its standard offering and publish that list so veterans and staff can see what is routinely supplied.
The statutory language anchors the formulary in evidence-based selection and asks the VA to solicit input from veterans and the public as part of development.
Operationally, the VA will need new governance to run the formulary: committees or staff to review evidence, a process for adding or removing items, and a public-facing publication platform that is kept current. The bill also pushes the VA to support the formulary through contracting and training, which means procurement teams will likely shift toward systemwide agreements and logistics planning that ensure items on the formulary can be accessed “at or through” every VA facility.The statute preserves clinician judgment by requiring an exceptions process for medically necessary non-formulary items and adds a monitoring duty so the VA can track those exceptions and consider whether to add those items to the formulary.
That creates an operational feedback loop — data from exceptions should feed formulary updates — but also requires IT, data collection, and adjudication systems that do not currently exist in a coordinated way across the enterprise.Finally, the bill points the VA to its Pharmacy Benefits Management Services as a model to adapt for formulary management and safety. Translating pharmacy formulary governance to prosthetics brings useful tools (evidence review frameworks, utilization monitoring, contracting strategies) but also key differences: devices and services have different supply chains, customization needs, and clinician workflows than medications, so the VA will need tailored policies rather than a straight port of PBMS procedures.
The Five Things You Need to Know
The bill inserts a new section 1709D into chapter 17 of Title 38 establishing a formal Prosthetic and Rehabilitative Items and Services Formulary.
The Secretary must ensure every item and service included on the Formulary is available at or through all VA facilities.
The VA must publish the Formulary on its website, update it periodically, and communicate its contents and appeals information to veterans.
The bill requires the VA to create a clinician exception process for prescribing non-formulary items when medically necessary and to monitor those requests to assess consistency and potential addition to the Formulary.
The Secretary must enter into contracts as necessary and provide training for clinicians and staff, and must consider adapting Pharmacy Benefits Management Services’ formulary management approaches for this program.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Creates the Prosthetic and Rehabilitative Items and Services Formulary
This subsection is the statutory hook: it directs the Secretary to establish a named Formulary for furnishing prosthetic and rehabilitative items and services under VA medical care authorities. Practically, this converts a set of discretionary local practices into an enterprise-level object that the VA must manage and publicly maintain.
Development standards: input, evidence, and availability
This subsection sets three development rules: solicit veteran and public input, rely on the best available evidence to select items and services, and ensure listed items are accessible at or through every VA facility. Each rule creates a different implementation burden — public engagement processes, an evidence-review function, and logistics/supply assurances — and ties them together as mandatory considerations for formulary content.
Publication and veteran communication
The VA must publish the Formulary on a Department website and update it periodically, and must communicate the Formulary contents and appeals pathways to veterans. That requires a public-facing, searchable resource and internal workflows so front-line staff can explain availability and the steps for veterans to challenge or appeal decisions.
Support mechanisms: contracting and training
The statute explicitly authorizes the Secretary to enter into contracts necessary to support formulary availability and requires training for clinicians and other VA staff. Expect central contracting, distribution planning, and curricula development to follow — not optional add-ons, but necessary pieces for the Formulary to be operational at scale.
Exceptions process and monitoring
This provision preserves clinician authority to request non-formulary items when medically necessary and requires the VA to monitor those requests for consistency and to determine if items should be added to the Formulary. That creates a formal feedback loop: exceptions are both a clinical safety valve and a source of evidence for expansion of the standard offering.
Mandate to consider PBMS approaches
The Secretary must consider how the VA’s Pharmacy Benefits Management Services manages formularies and medication safety and adapt those practices where appropriate. This directs VA leadership to look to an existing internal model while implicitly acknowledging that prosthetics will require different operational solutions.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans entitled to VA medical care — gain greater transparency about which prosthetic and rehabilitative items VA intends to furnish and a clearer mechanism to seek non-formulary items when clinically necessary.
- VA clinical staff — receive uniform guidance and training tied to a national formulary, which can reduce local variability in device selection and make cross-facility referrals more predictable.
- VA procurement and logistics teams — benefit from a centralized list that enables systemwide contracting and inventory planning, potentially improving economies of scale and supply predictability.
- Veterans’ advocacy organizations and oversight bodies — benefit from clearer public information and a published appeals pathway, improving accountability and the ability to track service availability.
Who Bears the Cost
- VA facilities and supply-chain operations — must implement nationwide availability commitments, potentially incurring transportation, stocking, and inventory-management costs to ensure formulary items are accessible at or through every facility.
- VA clinicians and administrators — face new documentation, training, and exception-request workflows that add administrative time and require integration into clinical processes.
- Small or niche prosthetic suppliers — may face higher barriers to entry if VA moves toward centralized contracts favoring larger vendors with national distribution capabilities.
- The VA central budget — will need to fund contracting transitions, IT and data systems for monitoring exceptions, public publication platforms, and workforce training without an explicit appropriation mechanism in the bill.
Key Issues
The Core Tension
The central dilemma is between standardizing access to produce consistent, transparent VA benefits nationwide and preserving clinician discretion and local flexibility to meet individual veterans’ needs — a trade-off that shifts benefits toward predictability and purchasing leverage but risks administrative complexity, supply constraints, or reduced innovation if not managed carefully.
The bill sets clear direction but leaves several implementation levers unspecified. It requires that formulary items be “available at or through” all VA facilities, but does not define the standard of availability (on-site inventory versus regional fulfillment on request) or timelines for procurement and distribution.
That ambiguity will be consequential: an on-site availability standard drives different contracting and warehousing choices than a regional or vendor-managed fulfillment standard.
The exceptions-and-monitoring approach creates a data-driven path to expand the formulary, but it also raises practical tensions. If the monitoring and adjudication process is slow or onerous, veterans may experience delays in access; if it is too permissive, the formulary may offer limited standardization benefits.
Operationalizing monitoring requires IT changes, consistent coding and reporting across facilities, and clear thresholds for when exception volumes or outcomes trigger formal review — none of which the statute specifies. Finally, adapting pharmacy formulary practices to prosthetics is sensible as a starting point but imperfect: devices are often customized, have longer lifecycles, and depend on fitting and rehabilitation services in ways drugs do not.
The VA will need to translate PBMS processes to a materially different supply-and-care model rather than apply them wholesale.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.